MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
about
Emerging Role of miRNAs in the Drug Resistance of Gastric CancerDysregulation of non-coding RNAs in gastric cancerPerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsRole of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancerMolecular mechanisms of chemoresistance in gastric cancerEpigenetic roles in the malignant transformation of gastric mucosal cellsPmRunt regulated by Pm-miR-183 participates in nacre formation possibly through promoting the expression of collagen VI-like and Nacrein in pearl oyster Pinctada martensiimiR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cellsImpact of tumour epithelial subtype on circulating microRNAs in breast cancer patientsDifferential expression profiling of spleen microRNAs in response to two distinct type II interferons in Tetraodon nigroviridis.MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened.Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells.Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance.Sam68 reduces cisplatin-induced apoptosis in tongue carcinoma.MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B geneDiagnostic and prognostic value of miR-106a in colorectal cancer.Interaction between gastric cancer stem cells and the tumor microenvironment.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy.MiR-195 inhibits the growth and metastasis of NSCLC cells by targeting IGF1R.MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.How to stomach an epigenetic insult: the gastric cancer epigenome.MiR-20a-5p represses the multi-drug resistance of osteosarcoma by targeting the SDC2 gene.Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
P2860
Q26752006-8EAD1525-FBE8-4CA7-A97C-3821F363FF14Q26780293-24A2513E-35B3-4832-A4D9-9DCDF97880E8Q27012898-9C8CB38C-D812-4A87-912A-CE2DB488F989Q28067449-F71D9873-C692-4DD8-A8E9-4059543C86B5Q28069259-D60EB6C3-B20C-446B-AE04-5F834E9CA575Q28070086-2D71F08D-76EE-4DE8-AF76-08F8B4E8738CQ33751853-EA1CCD2D-20B3-48E1-9984-5AA08EF78263Q34151444-67EC49F8-81E9-4183-8412-5BEBDA042F77Q35120108-3C644DF5-35BA-42C1-877D-CA2003AA8FB3Q35163626-4D751E55-A97E-429E-95ED-4175C9C17E8AQ35293359-34429013-481B-4D73-84FC-CEB295048289Q35740131-55CA76A7-09A7-4846-9E47-088BFEE11DD8Q35918997-796E96E1-D60A-4B76-A024-18EBFF96D165Q36545132-6B38F669-571D-4E22-9623-243D710025F5Q37013250-E9D20868-5594-49D4-AB12-DDA095EBD296Q37013255-5A981A27-46DE-4F4C-99D0-EEA6BB37112BQ37138844-531528FA-D1E7-449B-B73C-66E75EC97235Q37154118-02752317-1713-4866-A3D3-F79ABDFC60CBQ37706295-9D467903-714A-4AB2-BEDE-E67DC7751644Q38197931-2765A28C-9FB9-45FE-95F6-CEFC32593CF0Q38202662-0B29DF6B-9DB0-413D-AFCF-5EDC015E259BQ38514962-A4DE6881-64F3-4D7E-B599-155BE66E2156Q38710597-838FB3D4-3746-4C37-977F-A0F971EDAFECQ38990522-C72EF473-3480-4188-BE9F-94AA020E01D3Q39033216-44AAEBC4-91E2-44B6-A1EF-2B5273566E9EQ39096209-E7F8BC66-D981-4A07-B6BD-35FF71AB6BFAQ39312802-A4274049-CAF2-41E6-8E6D-9A27F2C7670FQ47133945-DE5DC51E-5CDA-4D36-8C57-8AE1537C7601Q47673159-E026F890-527D-4CC1-8167-07B3EB84495A
P2860
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@en
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@nl
type
label
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@en
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@nl
prefLabel
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@en
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@nl
P2093
P2860
P1433
P1476
MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
@en
P2093
P2860
P304
P356
10.1016/J.FEBSLET.2013.06.058
P407
P577
2013-08-08T00:00:00Z